Literature DB >> 22198557

Assessing behavioural effects of chronic HPA axis activation using conditional CRH-overexpressing mice.

Nina Dedic1, Chadi Touma, Cristoph P Romanowski, Marcel Schieven, Claudia Kühne, Martin Ableitner, Ailing Lu, Florian Holsboer, Wolfgang Wurst, Mayumi Kimura, Jan M Deussing.   

Abstract

The corticotropin-releasing hormone (CRH) and its cognate receptors have been implicated in the pathophysiology of stress-related disorders. Hypersecretion of central CRH and elevated glucocorticoid levels, as a consequence of impaired feedback control, have been shown to accompany mood and anxiety disorders. However, a clear discrimination of direct effects of centrally hypersecreted CRH from those resulting from HPA axis activation has been difficult. Applying a conditional strategy, we have generated two conditional CRH-overexpressing mouse lines: CRH-COE ( Del ) mice overexpress CRH throughout the body, while CRH-COE ( APit ) mice selectively overexpress CRH in the anterior and intermediate lobe of the pituitary. Both mouse lines show increased basal plasma corticosterone levels and consequently develop signs of Cushing's syndrome. However, while mice ubiquitously overexpressing CRH exhibited increased anxiety-related behaviour, overexpression of CRH in the pituitary did not produce alterations in emotional behaviour. These results suggest that chronic hypercorticosteroidism alone is not sufficient to alter anxiety-related behaviour but rather that central CRH hyperdrive on its own or in combination with elevated glucocorticoids is responsible for the increase in anxiety-related behaviour. In conclusion, the generated mouse lines represent valuable animal models to study the consequences of chronic CRH overproduction and HPA axis activation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198557     DOI: 10.1007/s10571-011-9784-0

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  62 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Chronic overexpression of corticotropin-releasing factor from the central amygdala produces HPA axis hyperactivity and behavioral anxiety associated with gene-expression changes in the hippocampus and paraventricular nucleus of the hypothalamus.

Authors:  Elizabeth I Flandreau; Kerry J Ressler; Michael J Owens; Charles B Nemeroff
Journal:  Psychoneuroendocrinology       Date:  2011-05-26       Impact factor: 4.905

Review 3.  Dissecting the genetic effect of the CRH system on anxiety and stress-related behaviour.

Authors:  Jan M Deussing; Wolfgang Wurst
Journal:  C R Biol       Date:  2005-02       Impact factor: 1.583

4.  Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotropin-releasing hormone.

Authors:  Anneloes Dirks; Lucianne Groenink; Marlies Iutje Schipholt; Jan van der Gugten; Theo H Hijzen; Mark A Geyer; Berend Olivier
Journal:  Biol Psychiatry       Date:  2002-04-01       Impact factor: 13.382

5.  Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.

Authors:  F Tronche; C Kellendonk; O Kretz; P Gass; K Anlag; P C Orban; R Bock; R Klein; G Schütz
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

6.  Mood changes in response to psychosocial stress in healthy young women: effects of pretreatment with cortisol.

Authors:  Serkan Het; Oliver T Wolf
Journal:  Behav Neurosci       Date:  2007-02       Impact factor: 1.912

7.  Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

Authors:  M P Stenzel-Poore; S C Heinrichs; S Rivest; G F Koob; W W Vale
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

8.  Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.

Authors:  Hossein Tezval; Olaf Jahn; Cedomir Todorovic; Astrid Sasse; Klaus Eckart; Joachim Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

9.  Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior.

Authors:  A Lu; M A Steiner; N Whittle; A M Vogl; S M Walser; M Ableitner; D Refojo; M Ekker; J L Rubenstein; G K Stalla; N Singewald; F Holsboer; C T Wotjak; W Wurst; J M Deussing
Journal:  Mol Psychiatry       Date:  2008-05-13       Impact factor: 15.992

10.  Mice selected for high versus low stress reactivity: a new animal model for affective disorders.

Authors:  Chadi Touma; Mirjam Bunck; Lisa Glasl; Markus Nussbaumer; Rupert Palme; Hendrik Stein; Michael Wolferstätter; Ramona Zeh; Marina Zimbelmann; Florian Holsboer; Rainer Landgraf
Journal:  Psychoneuroendocrinology       Date:  2008-05-23       Impact factor: 4.905

View more
  13 in total

Review 1.  Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Authors:  R Parrish Waters; Marion Rivalan; D A Bangasser; J M Deussing; M Ising; S K Wood; F Holsboer; Cliff H Summers
Journal:  Neurosci Biobehav Rev       Date:  2015-08-10       Impact factor: 8.989

2.  Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety.

Authors:  J Megan Gray; Haley A Vecchiarelli; Maria Morena; Tiffany T Y Lee; Daniel J Hermanson; Alexander B Kim; Ryan J McLaughlin; Kowther I Hassan; Claudia Kühne; Carsten T Wotjak; Jan M Deussing; Sachin Patel; Matthew N Hill
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

3.  Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating.

Authors:  Elizabeth Flandreau; Victoria Risbrough; Ailing Lu; Martin Ableitner; Mark A Geyer; Florian Holsboer; Jan M Deussing
Journal:  Psychoneuroendocrinology       Date:  2014-12-11       Impact factor: 4.905

Review 4.  Treatment-resistant depression: are animal models of depression fit for purpose?

Authors:  Paul Willner; Catherine Belzung
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

Review 5.  Energetic stress: The reciprocal relationship between energy availability and the stress response.

Authors:  C S Harrell; C F Gillespie; G N Neigh
Journal:  Physiol Behav       Date:  2015-10-09

6.  Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function.

Authors:  J Megan Gray; Christopher D Wilson; Tiffany T Y Lee; Quentin J Pittman; Jan M Deussing; Cecilia J Hillard; Bruce S McEwen; Jay Schulkin; Ilia N Karatsoreos; Sachin Patel; Matthew N Hill
Journal:  Psychoneuroendocrinology       Date:  2016-01-11       Impact factor: 4.905

7.  NRSF-dependent epigenetic mechanisms contribute to programming of stress-sensitive neurons by neonatal experience, promoting resilience.

Authors:  A Singh-Taylor; J Molet; S Jiang; A Korosi; J L Bolton; Y Noam; K Simeone; J Cope; Y Chen; A Mortazavi; T Z Baram
Journal:  Mol Psychiatry       Date:  2017-01-10       Impact factor: 15.992

8.  Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood.

Authors:  N Dedic; M L Pöhlmann; J S Richter; D Mehta; D Czamara; M W Metzger; J Dine; B T Bedenk; J Hartmann; K V Wagner; A Jurik; L M Almli; A Lori; S Moosmang; F Hofmann; C T Wotjak; G Rammes; M Eder; A Chen; K J Ressler; W Wurst; M V Schmidt; E B Binder; J M Deussing
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

9.  Behavioral Studies and Genetic Alterations in Corticotropin-Releasing Hormone (CRH) Neurocircuitry: Insights into Human Psychiatric Disorders.

Authors:  Gloria Laryea; Melinda G Arnett; Louis J Muglia
Journal:  Behav Sci (Basel)       Date:  2012-06-21

10.  An N-ethyl-N-nitrosourea induced corticotropin-releasing hormone promoter mutation provides a mouse model for endogenous glucocorticoid excess.

Authors:  Liz Bentley; Christopher T Esapa; M Andrew Nesbit; Rosie A Head; Holly Evans; Darren Lath; Cheryl L Scudamore; Tertius A Hough; Christine Podrini; Fadil M Hannan; William D Fraser; Peter I Croucher; Matthew A Brown; Steve D M Brown; Roger D Cox; Rajesh V Thakker
Journal:  Endocrinology       Date:  2013-12-03       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.